Project Spotlight Tour of Biotech Lab Research Building in Cambridge Over 50 CREW Boston members were hosted by Kathryn Lachelt Brown from Forest City and Kelly Flynn from Takeda Pharmaceuticals to tour the biotech lab research building just nearing completion of construction at 300 Massachusetts Avenue in Cambridge and they provided background about the development and the unique nature of biotech lab research space. The 300 Mass Avenue building, under development by Forest City in joint venture with MIT, features 230,000 square feet of advanced research, lab and office space for Takeda Pharmaceuticals, and will expand Takeda’s presence in University Park, a 2.5 million square foot mixed use project developed by Forest City near Central Square. Additionally, 300 Mass Avenue will bring 15,000 square feet of ground floor retail space that is fully leased to an exciting array of local retail operators to enliven the public realm in this portion of Cambridge.